Sepsis & infection

Resuscitation strategies incorporating peripheral perfusion targets in septic shock: A systematic review and meta-analysis of randomized controlled trials

J Crit CarePublished systematic review and meta-analysis of randomized controlled trials

Pooled result · 28/30-day mortalityResult — go to the resultRelative risk 0.92 95% CI 0.78–1.09

Authors' conclusion

In early septic shock, RSIPPT were associated with a modest reduction in resuscitation fluid during the first 6-8 h. A mortality reduction was not demonstrated, although clinically important benefit or harm cannot be excluded. Differences in intervention algorithms and comparators limit attribution of these findings to peripheral perfusion monitoring itself.

Study context

Population
Patients with septic shock
Participants
2,180 patients5 randomized controlled trials (RCTs)
Comparison
Resuscitation strategies incorporating peripheral perfusion targets (RSIPPT) compared with conventional strategies
Outcome
28/30-day mortality
Follow-up
28/30 days
Methodological detailsRCTs, random-effects model, RoB 2, GRADE
  • RCTs
  • Random-effects model
  • RoB 2
  • GRADE

Pooled result

28/30-day mortality

Relative risk

0.92

95% CI 0.78–1.09

RSIPPTvs Conventional strategies
RR 0.92 (95% CI 0.78–1.09)

As reported in the abstract

Further pooled results

OutcomeRR (95% CI)
90-day mortality · three RCTs; I2 = 0%; low CoE0.94 (0.83–1.05)
OutcomeMD (mL) (95% CI)
Fluid during resuscitation · first 6-8 hThree RCTs; I2 = 1%; low CoE−264.53 (−425.28 to −103.77)

Intensive care unit or hospital length of stay, organ dysfunction, vasopressor-free days, ventilator-free days, renal replacement therapy-free days

No significant differences

Original publication

Resuscitation strategies incorporating peripheral perfusion targets in septic shock: A systematic review and meta-analysis of randomized controlled trials. J Crit Care. Published 13 November 2026. doi:10.1016/j.jcrc.2026.155829

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.